Wilson Sonsini Goodrich & Rosati advised NEA and Abingworth on the transaction.Escient Pharmaceuticals announced that it had raised $120 million through a Series C Financing led…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
